Knowledge

Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.

Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.

Follow us:

Publications

News

FDA eases some postmarket adverse event reporting deadlines during COVID-19 pandemic
Registered Content

During the ongoing COVID-19 pandemic, the U.S. Food and Drug Administration (FDA) expects that workforces will be reduced at the same time that the use of medical products will increase....

News

COVID-19: Daily Report for Life Sciences and Health Care Companies

The Daily Report is a compilation of COVID-19 (coronavirus) news briefs from around the worldto helplife sciences and health care companies stay current in this challenging...

Hogan Lovells Publications

Navigating Limits on Product Liability under the PREP Act for COVID-19 Clinical Trial Activities

While numerous entities are responding with impressive speed and diligence in working to develop and deploy various COVID-19 countermeasures, some from the Plaintiffs bar are already...

News

COVID-19: Daily Report for Life Sciences and Health Care Companies

The Daily Report is a compilation of COVID-19 (coronavirus) news briefs from around the worldto helplife sciences and health care companies stay current in this challenging...

Hogan Lovells Publications

Antitrust, Competition, and Economic Regulation Quarterly Newsletter - Winter 2020

Read the roundup of news on antitrust, competition and economic regulation (ACER) in the Winter's edition of our quarterly ACER newsletter.

News

COVID-19’s impact on clinical trials prompts FDA to issue guidance to assist with study conduct
Registered Content

On Wednesday, March 18, the U.S. Food and Drug Administration published the guidance“Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic." The guidance...

News

The impact of COVID-19 on the hardest hit industries and how to minimize the damage

COVID-19 has produced an instant global economic shock. It is unclear whether the economic effects will be short-term – like the post-9/11 recession – or long-term – like...

News

The global impact of COVID-19 on clinical trials and countermeasure development
Registered Content

The World Health Organization (WHO) has determined that the 2019 novel coronavirus is a “global pandemic” and President Trump has declared a national emergency as the impact of...

Insights

FTC and FDA intensify efforts to promote biologics competition
Registered Content

On March 9, 2020, the U.S. Federal Trade Commission (FTC) and Food and Drug Administration (FDA) (collectively, "the Agencies") held a public workshop to discuss competition...

Loading data